Clinical Efficacy and Safety of Nifedipine and Irbesartan in Treatment of Type 2 Diabetes with Hypertension
Wu Sh
Abstract
Wu Sh
Abstract
Objective: To assess the efficiacy and safety of nifedipine and irbesartan for treatment of type 2 diabetes with hypertension. Method: 148 patients with type 2 diabetes with hypertension were divided into two groups,The observation group of 74 cases with nifedipine and irbesartan treatment,while control group of 74 patients used nifedipine. Result: After treatment,the total effective rate of observation group was100.0%,significantly higher than the control group,and the difference was statistically significant( P 0.05),And the observation group with systolic blood pressure,diastolic blood pressure and other indicators significant improved,the difference was statistically significant( P0.05). Conclusion: Nifedipine and irbesartan for treatment of type 2 diabetic patients with hypertension has a very significant effect,while the patient's blood glucose levels would not adversely impact,and it is worthy of clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To assess the efficiacy and safety of nifedipine and irbesartan for treatment of type 2 diabetes with hypertension. Method: 148 patients with type 2 diabetes with hypertension were divided into two groups,The observation group of 74 cases with nifedipine and irbesartan treatment,while control group of 74 patients used nifedipine. Result: After treatment,the total effective rate of observation group was100.0%,significantly higher than the control group,and the difference was statistically significant( P 0.05),And the observation group with systolic blood pressure,diastolic blood pressure and other indicators significant improved,the difference was statistically significant( P0.05). Conclusion: Nifedipine and irbesartan for treatment of type 2 diabetic patients with hypertension has a very significant effect,while the patient's blood glucose levels would not adversely impact,and it is worthy of clinical application.
Key concepts: Irbesartan, Medicine, Nifedipine, Blood pressure, Type 2 diabetes, Significant difference, Diabetes mellitus, Internal medicine